Skip to main content

Together we are beating cancer

Donate now

Henry Scowcroft

Henry Scowcroft is an award-winning science writer and author of Cross Everything, an acclaimed memoir about cancer. He worked at Cancer Research UK between 2003 and 2022, and is now a freelance communications consultant, writer and editor.
Showing 12 out of 273 results
Alan
  • Health & Medicine
  • Science & Technology

Our milestones: the birth of abiraterone for prostate cancer

We look back to the 1990s, and to our 'first-in-man' trial of prostate cancer drug abiraterone - a vital step in the drug's development We look back to the 1990s, and to our 'first-in-man' trial of prostate cancer drug abiraterone - a vital step in the drug's development

by Henry Scowcroft | Analysis | 21 September 2015

21 September 2015

This entry is part 24 of 30 in the series Our milestones

We quiz our chief clinician, Professor Peter Johnson, to get his take on the history of cancer immunotherapy and where the field is heading. We quiz our chief clinician, Professor Peter Johnson, to get his take on the history of cancer immunotherapy and where the field is heading.

by Henry Scowcroft | Analysis | 17 September 2015

17 September 2015

GP appointment patient

We look at welcome new stats published today, show that the number of cancer patients diagnosed in an emergency is falling. We look at welcome new stats published today, show that the number of cancer patients diagnosed in an emergency is falling.

by Henry Scowcroft | Analysis | 16 September 2015

16 September 2015

  • Science & Technology
  • Health & Medicine

Two years on for our pioneering TRACERx lung cancer study

Two years ago we launched a pioneering £15m lung cancer study. Find out what's happened since, through the eyes of Terrence, a patient taking part. Two years ago we launched a pioneering £15m lung cancer study. Find out what's happened since, through the eyes of Terrence, a patient taking part.

by Henry Scowcroft | Analysis | 2 September 2015

2 September 2015

vitamin pills

This morning's headlines about vitamin B3 and skin cancer were a little over the top. Here are our thoughts on the research behind the story This morning's headlines about vitamin B3 and skin cancer were a little over the top. Here are our thoughts on the research behind the story

by Henry Scowcroft | Analysis | 15 May 2015

15 May 2015